Literature DB >> 9250438

Acute effects of ketamine in the holeboard, the elevated-plus maze, and the social interaction test in Wistar rats.

J S Silvestre1, R Nadal, M Pallarés, N Ferré.   

Abstract

Although noncompetitive NMDA receptor antagonists have shown an anxiolyticlike profile in several studies, such effects have not been observed consistently. Previous studies with ketamine, a noncompetitive NMDA antagonist, have employed only shock tests of anxiety based on conflict procedures. In the present experiment, the effect of an acute low dose of ketamine (7 mg/kg) was examined in adult male Wistar rats tested in three nonconflict tests: holeboard, social interaction, and elevated plus-maze paradigms. The results showed that ketamine decreased time spent in active social interaction and the number of rearings and central activity in the social interaction test. It also decreased the number of entries into the percentage of time spent in open arms and the total number of entries in the elevated plus-maze. No significant effect was observed in head dipping in the holeboard test, although the number of crossings did increase. These results suggest an anxiogeniclike effect of ketamine in contrast with results previously described for noncompetitive NMDA receptor antagonists. These effects of ketamine are more similar to those described for stimulant drugs such as caffeine, cocaine, or amphetamine in anxiety tests.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9250438

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  38 in total

Review 1.  New therapeutic targets for mood disorders.

Authors:  Rodrigo Machado-Vieira; Giacomo Salvadore; Nancy DiazGranados; Lobna Ibrahim; David Latov; Cristina Wheeler-Castillo; Jacqueline Baumann; Ioline D Henter; Carlos A Zarate
Journal:  ScientificWorldJournal       Date:  2010-04-13

Review 2.  Translating glutamate: from pathophysiology to treatment.

Authors:  Daniel C Javitt; Darryle Schoepp; Peter W Kalivas; Nora D Volkow; Carlos Zarate; Kalpana Merchant; Mark F Bear; Daniel Umbricht; Mihaly Hajos; William Z Potter; Chi-Ming Lee
Journal:  Sci Transl Med       Date:  2011-09-28       Impact factor: 17.956

3.  Low doses of the NMDA receptor antagonists, MK-801, PEAQX, and ifenprodil, induces social facilitation in adolescent male rats.

Authors:  Melissa Morales; Elena I Varlinskaya; Linda P Spear
Journal:  Behav Brain Res       Date:  2013-05-04       Impact factor: 3.332

4.  The group II metabotropic glutamate receptor agonist LY379268 reduces toluene-induced enhancement of brain-stimulation reward and behavioral disturbances.

Authors:  Ming-Huan Chan; Yi-Ling Tsai; Mei-Yi Lee; Astrid K Stoker; Athina Markou; Hwei-Hsien Chen
Journal:  Psychopharmacology (Berl)       Date:  2015-06-06       Impact factor: 4.530

5.  The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents.

Authors:  Adam L Halberstadt; Natalia Slepak; James Hyun; Mahalah R Buell; Susan B Powell
Journal:  Psychopharmacology (Berl)       Date:  2016-01-13       Impact factor: 4.530

6.  Rapid well-plate assays for motor and social behaviors in larval zebrafish.

Authors:  Qiaosen Shen; Lisa Truong; Michael T Simonich; Changjiang Huang; Robyn L Tanguay; Qiaoxiang Dong
Journal:  Behav Brain Res       Date:  2020-05-16       Impact factor: 3.332

7.  Impaired social behaviors and minimized oxytocin signaling of the adult mice deficient in the N-methyl-d-aspartate receptor GluN3A subunit.

Authors:  Jin Hwan Lee; James Ya Zhang; Zheng Zachory Wei; Shan Ping Yu
Journal:  Exp Neurol       Date:  2018-03-16       Impact factor: 5.330

8.  The effects of an acute challenge with the NMDA receptor antagonists, MK-801, PEAQX, and ifenprodil, on social inhibition in adolescent and adult male rats.

Authors:  Melissa Morales; Linda P Spear
Journal:  Psychopharmacology (Berl)       Date:  2013-09-17       Impact factor: 4.530

Review 9.  Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders.

Authors:  Rodrigo Machado-Vieira; Giacomo Salvadore; Lobna A Ibrahim; Nancy Diaz-Granados; Carlos A Zarate
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 10.  Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion.

Authors:  Christopher Barkus; Stephen B McHugh; Rolf Sprengel; Peter H Seeburg; J Nicholas P Rawlins; David M Bannerman
Journal:  Eur J Pharmacol       Date:  2009-10-15       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.